|
|
Build Your Online Product Catalogs?
| Product Name: |
Buy Artemisinin Powder/nootropic@ycgmp.com
|
| Supply Ability: |
500kg/month |
| Related proudcts |
artemisinin, |
| Specifications |
99% |
| Price Term: |
CNF |
| Port of loading: |
HK/Shanghai/Shenzhen |
| Minimum Order |
5g |
| Unit Price: |
$1 |
|
Artemisinin
Product Name: Artemisinin
CAS: 63968-64-9
MF: C15H22O5
MW: 282.3322
Purity: 99%
MP: 156-157â„?
BP: 389.899°C at 760 mmHg
FP: 171.953°C
Density: 1.247g/cm3
Grade: Pharmaceutical Grade
Appearance: White Powder
Artemisinin, also called qinghaosu, antimalarial drug derived from the sweet wormwood plant, Artemisia annua. Artemisinin is a sesquiterpene lactone and is distilled from the dried leaves or flower clusters of A. annua.
Artemisinin may be administered orally, intramuscularly, or as a suppository. The drug reaches peak plasma levels within hours after administration and acts rapidly, significantly reducing malaria parasite burden in the first few days of treatment. Artesunate is unique among the artemisinin-derived agents because it can be administered intravenously, enabling the drug to take immediate effect.
Antimalarial
Artemisinin is effective against all the malaria-causing protozoal organisms in the genus Plasmodium. The drug is particularly useful in the treatment of infections involving chloroquine-resistant parasites and infections involving multidrug-resistant P. falciparum, which is the deadliest of the malaria protozoans. Artemisinin targets Plasmodium organisms in the schizont stage of development.
Stacking
Because artemisinin and its derivatives have a short duration of action and target malaria parasites in a specific stage of their life cycle, there is a high rate of disease relapse associated with the drugs when they are used alone in single-agent therapy. As a result, they are usually used in combination with other, longer-acting antimalarial drugs.
Examples of first-line artemisinin-based stack therapies used in the treatment of malaria include artesunate-mefloquine, artemether-lumefantrine, and artesunate-amodiaquine. Although these stack therapies also have proved valuable in preventing the emergence of artemisinin-resistant parasites, the persistent use of single-agent artemisinin therapy in some parts of the world has led to the development |
| Company: |
Hangzhou Fuluo Biological Technology Co.,Ltd
|
| Contact: |
Ms. Cindy Lee |
| Address: |
4#Xinfeng Road,Hongjie Street,Jianggan District |
| Postcode: |
310017 |
| Tel: |
86-0571-87963072 |
| Fax: |
86-0571-87963072 |
| E-mail: |
|
|
|
|
Home
